Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease

Published:2023-02 Issue:1 Volume:24 Page:29-33
ISSN:1687-1979
Container-title:Arab Journal of Gastroenterology
language:en
Short-container-title:Arab Journal of Gastroenterology

Author:

El-Sayed Mohammad,Elserafy Magdy,El Raziky Maissa,Elakel Wafaa,Saad Yasmin,Fayad Tarek,Korany Mohamed,Mehrez Mai,Salama Rabab,Mahrous Maged,Zaki Ayman,Hassany Mohamed,Ammar Islam,Elsaeed Kadry,Elshazly Yehia,Doss Wahid

Publisher

Elsevier BV

Subject

Gastroenterology

Reference27 articles.

1. Outcomes of hepatitis C virus treatment with ledipasvir/sofosbuvir in Mongolian population: successes and challenges facing scale-up of care;Kang;Clin Mol Hepatol,2021

2. Epidemiology of hepatitis C virus infection;Roudot-Thoraval;Clin Res Hepatol Gastroenterol,2021

3. Chronic hepatitis C infection is associated with insulin resistance and lipid profiles;Dai;J Gastroenterol Hepatol,2015

4. Hepatitis C and renal disease: An update;Meyers;Am J Kidney Dis,2003

5. Meta-analysis ofobservational studies: Hepatitis C and survival after renal transplant;Fabrizi;J Viral Hepat,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety Analysis of Antiviral Drugs Approved for COVID-19 in Saudi Arabia;International Journal of Pharmacology;2023-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP